title: [Targeting oxidative metabolism to treat leukemia?].
authors.forename: Céline
authors.initials: C
authors.lastname: Callens
authors.forename: Ivan C
authors.initials: IC
authors.lastname: Moura
authors.forename: Olivier
authors.initials: O
authors.lastname: Hermine
mesh_terms: D000818:Animals; D002454:Cell Differentiation / Q000187:drug effects; D029721:Drosophila Proteins / Q000502:physiology; D004331:Drosophila melanogaster / Q000166:cytology / Q000378:metabolism; D006412:Hematopoietic Stem Cells / Q000166:cytology / Q000187:drug effects; D006801:Humans; D007501:Iron / Q000502:physiology; D007502:Iron Chelating Agents / Q000494:pharmacology / Q000627:therapeutic use*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D015479:Leukemia, Myelomonocytic, Acute / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D008954:Models, Biological; D009363:Neoplasm Proteins / Q000037:antagonists & inhibitors; D014411:Neoplastic Stem Cells / Q000166:cytology / Q000187:drug effects; D015514:Oncogene Proteins, Fusion / Q000037:antagonists & inhibitors; D018384:Oxidative Stress; D063150:Polycomb Repressive Complex 1; D017382:Reactive Oxygen Species / Q000037:antagonists & inhibitors*; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology; D014212:Tretinoin / Q000627:therapeutic use; D014807:Vitamin D / Q000502:physiology
chemical_list: D029721:Drosophila Proteins; D007502:Iron Chelating Agents; D009363:Neoplasm Proteins; D015514:Oncogene Proteins, Fusion; C066770:Pc protein, Drosophila; D017382:Reactive Oxygen Species; C093476:promyelocytic leukemia-retinoic acid receptor alpha fusion oncoprotein; D014807:Vitamin D; D014212:Tretinoin; D007501:Iron; D063150:Polycomb Repressive Complex 1